155 related articles for article (PubMed ID: 22973723)
21. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.
Cheng AS; Li MS; Kang W; Cheng VY; Chou JL; Lau SS; Go MY; Lee CC; Ling TK; Ng EK; Yu J; Huang TH; To KF; Chan MW; Sung JJ; Chan FK
Gastroenterology; 2013 Jan; 144(1):122-133.e9. PubMed ID: 23058321
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.
Shen R; Pan S; Qi S; Lin X; Cheng S
Biochem Biophys Res Commun; 2010 Apr; 394(4):1047-52. PubMed ID: 20331975
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic factors in regulation of microRNA in colorectal cancers.
Vinci S; Gelmini S; Mancini I; Malentacchi F; Pazzagli M; Beltrami C; Pinzani P; Orlando C
Methods; 2013 Jan; 59(1):138-46. PubMed ID: 22989523
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family.
Wong KY; Yu L; Chim CS
Epigenomics; 2011 Feb; 3(1):83-92. PubMed ID: 22126155
[TBL] [Abstract][Full Text] [Related]
26. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation and colorectal cancer.
Matsubara N
Dis Colon Rectum; 2012 Jan; 55(1):96-104. PubMed ID: 22156874
[TBL] [Abstract][Full Text] [Related]
28. Role of DNA methylation in the development of diffuse-type gastric cancer.
Yamamoto E; Suzuki H; Takamaru H; Yamamoto H; Toyota M; Shinomura Y
Digestion; 2011; 83(4):241-9. PubMed ID: 21273772
[TBL] [Abstract][Full Text] [Related]
29. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer.
Chen WS; Leung CM; Pan HW; Hu LY; Li SC; Ho MR; Tsai KW
Oncol Rep; 2012 Sep; 28(3):1069-76. PubMed ID: 22766685
[TBL] [Abstract][Full Text] [Related]
30. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G
J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.
Otani K; Li X; Arakawa T; Chan FK; Yu J
Expert Rev Mol Diagn; 2013 Jun; 13(5):445-55. PubMed ID: 23782252
[TBL] [Abstract][Full Text] [Related]
32. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
Kaise M; Yamasaki T; Yonezawa J; Miwa J; Ohta Y; Tajiri H
Helicobacter; 2008 Feb; 13(1):35-41. PubMed ID: 18205664
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.
Kubo T; Toyooka S; Tsukuda K; Sakaguchi M; Fukazawa T; Soh J; Asano H; Ueno T; Muraoka T; Yamamoto H; Nasu Y; Kishimoto T; Pass HI; Matsui H; Huh NH; Miyoshi S
Clin Cancer Res; 2011 Aug; 17(15):4965-74. PubMed ID: 21673066
[TBL] [Abstract][Full Text] [Related]
34. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Sakakura C; Mitsufuji S; Hirohashi S; Inazawa J
Oncogene; 2006 Oct; 25(49):6554-62. PubMed ID: 16715143
[TBL] [Abstract][Full Text] [Related]
35. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis.
Xiao B; Zhu ED; Li N; Lu DS; Li W; Li BS; Zhao YL; Mao XH; Guo G; Yu PW; Zou QM
Oncol Rep; 2012 Feb; 27(2):559-66. PubMed ID: 22020746
[TBL] [Abstract][Full Text] [Related]
36. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.
Kim SK; Jang HR; Kim JH; Noh SM; Song KS; Kim MR; Kim SY; Yeom YI; Kim NS; Yoo HS; Kim YS
Biochem Biophys Res Commun; 2006 Oct; 349(3):1032-40. PubMed ID: 16959213
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
[TBL] [Abstract][Full Text] [Related]
38. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
Bao W; Fu HJ; Xie QS; Wang L; Zhang R; Guo ZY; Zhao J; Meng YL; Ren XL; Wang T; Li Q; Jin BQ; Yao LB; Wang RA; Fan DM; Chen SY; Jia LT; Yang AG
Gastroenterology; 2011 Dec; 141(6):2076-2087.e6. PubMed ID: 21925125
[TBL] [Abstract][Full Text] [Related]
39. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
40. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
Matsubara N
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
